Bortezomib Completed Phase 2 Trials for Peripheral T-Cell Lymphoma (PTCL) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00136565Study of Bortezomib Combined With ACVBP in Peripheral T-cell Lymphoma